Before the end of the regular trading session on Wednesday, Puma Biotechnology, Inc. (NASDAQ:PBYI) added $0.65 to its price. In the past year, Puma Biotechnology, Inc. (NASDAQ:PBYI) has seen its stock hit a 1-year high price of $136.90 as well as a 1-year low price of $47.00. When it comes to volume of trade, 1.31 million shares of this company’s stock changed hands.Currently, this public company’s quick ratio is 1.90, its debt-to-equity ratio is 0.85, and its current ratio is 1.90. This organization, right now, has a market cap of $2.00B, a beta score of 0.07 and its current ratio is 1.90.
Stifel Reiterated shares of Puma Biotechnology, Inc. (NASDAQ:PBYI) to a Buy rating in a report posted on Friday, May 11th, 2018. At the present, they have a price target for the Biotechnology set at $87. Several additional equities analysts have also published recent reports on PBYI stock. RBC Capital Mkts, for example, Reiterated Puma Biotechnology, Inc. to Sector Perform in a report that was made public on Friday, November 10th, 2017. Citigroup Reiterated a $164 price target on Puma Biotechnology, Inc. in a report from Friday, November 10th, 2017, while giving the stock to a Buy rating. In a report sent out on Monday, October 2nd, 2017, Stifel Reiterated the stock rating on Puma Biotechnology, Inc. to a Buy. Lastly, a Outperform rating on shares of Puma Biotechnology, Inc. was Reiterated by Credit Suisse, which also set a $136 price target on the company’s stock. In total, 2 Wall Street analysts have given this stock a hold rating, with 3 analysts rating it as a strong buy. At the time of writing, this stock has a consensus price target set at $92.33 and average analyst rating set to Moderate Buy.
There is a technical analysis indicator called the Relative Strength Index, or RSI, and analysts use it to measure momentum within a range of 0 to 100. When a stock’s RSI falls under 30, it is considered to be oversold. For Puma Biotechnology, Inc., specifically, the RSI metric has reached 40.83. Puma Biotechnology, Inc. (NASDAQ:PBYI) has lost -31.92% in value over the last three months, and -50.02% over the last six-month period. Over the last full year, the stock price has lost -35.11%.
Now let’s focus on another metric: volatility. This measurement indicates a stock’s predictable daily price range, and it is basically the range within which a day trader operates. When volatility levels are high, that means that profits and losses will also be high. After recently verifying the number, Puma Biotechnology, Inc. (NASDAQ:PBYI) stock has a volatility measurement of 4.03% for the week, with 4.27% volatility as observed from the past 30 days. The public company has 39.49M shares outstanding currently, as well as a market cap of $2.00B. This stock’s distance from its 20-day simple moving average is -1.87%, based on a recent bid, while its distance from the 50-day simple moving average is currently -13.66%. Meanwhile, it has a distance of -41.09% from the 200-day simple moving average. Today, this organization is sitting -63.08% away from its 52-week high price and 7.55% away from its 52-week low price.
For stock traders that are more focused on the more granular details, they tend to keep tabs on a metric called the Williams Percent Range or Willams %R. The Williams %R metric is a popular and widely-used technical indicator that was discovered by Larry Williams. It enables traders to identify when certain stocks have entered either overbought or oversold territory. Typically, seasoned stock traders will use the Williams %R metric in conjunction with other trend indicators to enable them to pinpoint possible turning points in a stock’s price path. Puma Biotechnology, Inc. (NASDAQ:PBYI)’s Williams Percent Range, or 14-day Williams %R, is sitting at 66.51 at the time of writing. Generally speaking, if the indicator rises above -20, the shares may be overbought. On the flip side, if the indicator goes below -80, it may mean that the stock has crossed over into oversold territory.
Investors frequently maintain their focus on the latest stock price resistance and support levels. The term “support” refers to the lower “floor” level where a stock may bounce back after it has dipped. If the share price can penetrate the first support level, investor attention will likely move to the second level. On the flip side, resistance means the very opposite. While a stock adds to its value, it might experience a drop as it hits a particular level of resistance. After a recent examination, this company’s shares’ first resistance level is sitting at 51.47. Meanwhile, investors are looking out for the first support level, which is 49.82.